Holuka Eugene Myron — SEC Form 4 filings

SEC reporting owner CIK 1678292. 7 Form 4 filings on record with FilingPulse; latest filed 2025-12-22.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-08-16 to 2025-12-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CITIUS ONCOLOGY, INC. (CTOR)Director55
Citius Pharmaceuticals, Inc. (CTXR)Director24

Form 4 filings — Holuka Eugene Myron

FiledFormIssuerReported transactionsSource
2025-12-224/ACITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 300,000 @ $0EDGAR
2025-12-014/ACITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 300,000 @ $0EDGAR
2025-09-234CITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 300,000 @ $0EDGAR
2024-12-164CITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2024-11-124Citius Pharmaceuticals, Inc. (CTXR)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2024-08-304Citius Pharmaceuticals, Inc. (CTXR)Option exercise (M): 2,415 @ $0.01 · Tax withholding (F): 48 @ $0.75 · Option exercise (M): 2,415 (derivative) @ $0EDGAR
2024-08-164CITIUS ONCOLOGY, INC. (CTOR)Grant/award (A): 150,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1678292 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →